share_log

华润医药:2024年公司拥有人应占溢利33.5亿元,同比减少13.1%

CHINARES PHARMA: In 2024, net income attributable to the company owners is 3.35 billion yuan, a decrease of 13.1% year-on-year.

Breakings ·  Mar 26 04:54

At noon on March 26, CHINARES PHARMA announced on the Hong Kong Stock Exchange that in 2024, the group recorded total revenue of 257.6733 billion yuan, a year-on-year increase of 5.3%; net income was 8.4032 billion yuan, a year-on-year increase of 8.1%; net income attributable to the company owners was 3.3509 billion yuan, a year-on-year decrease of 13.1%.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 221

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.